MARIJUANA INVESTMENT IDEAS #1

The USA voted to legalize cannabis – and created a huge windfall for tiny pot stocks. A small stake in this market could make many investors millionaires. This industry is growing as fast as any market.... except maybe CRYPTO!! Not software, not automotives or aerospace, not biotechnology, real estate, oil, gold, or smartphones. None of these industries are growing as fast as MARIJUANA . MANGO!

Now I know all the buzz is about JEFF SESSIONS AND DONALD TRUMP , and how they are going to ignore the state laws, and bring down the pain on the whole industry!! Well i call BULLSHIT. The voters have spoken at the polls, where 8 out of nine states voted yes on THEIR STATE BALLOT!!
And ever since then others states are coming from the wood work to get their piece of the tax REVENUE!! (which we all know they desperately need ). All I care about is can investors still make money in this market? And the answer is yes – and lots of it!!!

Medical Marijuana was worth about $1.5 billion in U.S. sales in 2013, but here are some projections over the next few years....

2017 $7.1 Billion
2020 $35 Billion
2029 $100 Billion

Being that marijuana industry is still in it's infancy, no one can really predict how big this industry could become!!

There is 83.1 million millennials, which are some of the most vocal supporters of legal cannabis, and over 65% of them want access to legal marijuana.

So lets get to a short essay on my first investment idea.

WONDER DRUGS

By far medical marijuana is the biggest segment of the emerging cannabis landscape. For decades the FDA has been quietly
been approving drugs that contain cannabinoids.

GW Pharmaceuticals PLC (Nasdaq ADR: GWPH)

52 week range $79-$137
AVG VOLUME: 265,000
DO I OWN THIS INVESTMENT : YES

Study after study has shown that up to two dozen medical conditions could be treated with marijuana. The following two ingredients have an impact on brain function and pain management. , cannabidiol (CBD) and tetrahydrocannabinol (THC).
Glaucoma sufferers, for example, have long known that pot can reduce ocular swelling.

The legal market for medical marijuana exceeded $4 billion in 2015. That got the scientists at GW Pharmaceuticals PLC (Nasdaq ADR: GWPH) thinking, why not build a business around CBD and THC? The body actually has three systems that regulate disease and pain. Researchers discovered that our body is also regulated by proteins called endocannabinoid receptors. THC and CBD go right to these receptors.

GW Pharma has focused on the impact of CBD, which targets the brain’s receptors that can control mood and brain seizures. For the 3 million epilepsy sufferers in the United States (and the 62 million sufferers worldwide), this relief was just not even imaginable just a few years ago!! Currently GWPH trades around $95 and has a market cap of 2.5 Billion and will be one of the biggest market cap company i will write about. But as this industry takes hold GWPH will be a clear winner and has first mover advantage. This stock has sold off a bit lately but that provides a good low entry point .
NONE OF THIS IS FORMAL INVESTMENT ADVICE AND YOU SHOULD ALWAYS CONTACT YOUR BROKER BEFORE INVESTING

FULL DISCLOSURE I OWN GWPH!

Due to this stocks volatility split entrys could be used.

50% at market 50% at say 15% lower than your entry.

GWPH is presenting at the 38 th GOLDMAN SACHS annual Global Heathcare Conference.